IRLAB Therapeutics Risk Adjusted Performance
| IRLAB-A Stock | | | SEK 1.55 0.03 1.97% |
The Risk Adjusted Performance reading for IRLAB Therapeutics AB is computed from historical trading observations. Values reflect historical observations within the available dataset. IRLAB Therapeutics has a market cap of 525.71 M, operating margin of -1.68%, current ratio of 9.19. Review
Risk vs Return Analysis for broader portfolio context. Tracking IRLAB Therapeutics AB in a portfolio helps measure its contribution to overall performance. Position weights are derived from the selected portfolio construction methodology. Broader economic conditions can influence IRLAB Therapeutics AB's company valuation — related indicators include
signals in bureau of labor statistics.
IRLAB Therapeutics AB has current Risk Adjusted Performance of
-0.06.
RAP | = | (ER[a] - RFR) * STD[b])/STD[b]RFR |
| = | -0.06 | |
Risk Adjusted Performance Peers Comparison
Risk Adjusted Performance Relative To Other Indicators
IRLAB Therapeutics AB is rated
below average in risk adjusted performance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors .
Other Technical Indicators